Tag: Celgene

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Celgene

J&J, Merck and Novartis announce slew of acquisitions as JPM 2024 kicks off

Added to Collection on: 2024-01-08 20:22:59

Tags for this article:

Novartis
Merck & Co.
Monoclonal antibody therapy
Oncology
Seagen
Celgene

Click the tags to see associated articles and topics

View Article Details
OS Therapies expands board with biopharma veterans - Investing.com

Added to Collection on: 2024-10-28 21:24:34

Tags for this article:

Bristol-Myers Squibb
Specialty drugs
Celgene
Biopharmaceutical
HER2
Halozyme

Click the tags to see associated articles and topics

View Article Details
What's Behind the Insider Buying on This High-Yield Stock? - The Globe and Mail

Added to Collection on: 2024-11-11 23:01:44

Tags for this article:

Bristol-Myers Squibb
AbbVie
Apixaban
Xanomeline/trospium chloride
Celgene
Bristol-Myers Squibb Company

Click the tags to see associated articles and topics

View Article Details
75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight

Added to Collection on: 2024-11-13 22:31:41

Tags for this article:

Multiple sclerosis
Autoimmune diseases
Biogen
Spinal muscular atrophy
Novartis
Sanofi
AstraZeneca
Roche
Celgene
Bristol-Myers Squibb
Eli Lilly and Company
Cladribine

Click the tags to see associated articles and topics

View Article Details
Bristol-Myers Squibb's SWOT analysis: navigating challenges in biopharma stock

Added to Collection on: 2024-12-30 23:20:09

Tags for this article:

Orphan drugs
Bristol-Myers Squibb
Immune system
Nivolumab
Programmed cell death protein 1
Clopidogrel
Idecabtagene vicleucel
Multiple myeloma
Celgene
Bristol-Myers Squibb's
Eliquis
Bristol-Myers Squibb

Click the tags to see associated articles and topics

View Article Details
General Proximity: $16 Million (Seed) Raised To Innovate Induced Proximity Medicines For ...

Added to Collection on: 2025-01-05 05:03:18

Tags for this article:

Craig M. Crews
Alnylam Pharmaceuticals
Astellas Pharma
Novartis
Roche
Squibb
Ginkgo Bioworks
Genentech
Celgene
Pharmaceutical industry
General Proximity
Aydin Senkut

Click the tags to see associated articles and topics

View Article Details
Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible ... - Nature

Added to Collection on: 2025-02-05 11:07:59

Tags for this article:

CAC 40
Sanofi
Bristol-Myers Squibb
Celgene
Amgen
AstraZeneca
Pharmaceutical industry
Pfizer
GSK plc
Takeda Pharmaceutical Company
Genmab
National Health Council
Takeda Pharmaceuticals
AbbVie
Genentech
Janssen Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Evolving Market Trends In The Immuno-Oncology Drugs Industry: - openPR.com

Added to Collection on: 2025-05-08 20:20:31

Tags for this article:

Research and development in the United States
Pharmaceutical companies
Biotechnology
Oncology
Sanofi
Celgene
Merck & Co.
Pfizer
Novartis
Biopharmaceutical
Takeda Pharmaceutical Company
Eli Lilly and Company

Click the tags to see associated articles and topics

View Article Details
MRD Monitoring May Help Redefine Long-Term Goals in Myeloma Therapy

Added to Collection on: 2025-06-01 23:28:31

Tags for this article:

Immunosuppressants
Oncology
Leukemia
Minimal residual disease
Orphan drugs
Multiple myeloma
Lenalidomide
Carfilzomib
MRD
Celgene
Cereblon E3 ligase modulator
Cancer treatment

Click the tags to see associated articles and topics

View Article Details
Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety

Added to Collection on: 2025-09-18 23:02:21

Tags for this article:

Orphan drugs
Daratumumab
Multiple myeloma
Lenalidomide
Cereblon E3 ligase modulator
CD38
Celgene
Proteasome inhibitor
Cevostamab
Isatuximab
Celgene Corporation
Pfizer
Canada
Toronto
Janssen Biotech Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo